Portfolio company
Chirality Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops chiral separation technology to provide pharmaceutical manufacturers with purer active ingredients for safer drug production.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Axiom Bio
This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.
Enantios
This company develops Raman optical activity measurement instruments and provides analytical services for pharmaceutical and chemical industries to characterise complex chiral molecules and biologics.
Asymmetric Suzuki Reactions
This company develops catalytic asymmetric cross-coupling reactions for pharmaceutical firms to create three-dimensional molecules for enhanced drug discovery and development.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
CATALYA
This company develops synthetic polymer platform technology to improve the solubility, stability and delivery of biopharmaceuticals for the pharmaceutical and biotechnology industries.
Pathfinder Bio
This company develops enzyme-based biomanufacturing processes to produce sustainable natural ingredients and fine chemicals for the pharmaceutical, cosmetic, food, and agri-tech industries.
Capra Biosciences
This company develops modular bioreactors to biomanufacture high-value chemicals like retinol and salicylic acid for pharmaceutical, personal care, and industrial customers.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
